Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

rs3827440, a nonsynonymous single nucleotide polymorphism within GPR174 gene in X chromosome, is associated with Graves' disease in Polish Caucasian population.

Szymański K, Miśkiewicz P, Pirko K, Jurecka-Lubieniecka B, Kula D, Hasse-Lazar K, Krajewski P, Bednarczuk T, Płoski R.

Tissue Antigens. 2014 Jan;83(1):41-4. doi: 10.1111/tan.12259. Epub 2013 Nov 30.

PMID:
24289805
2.

An X chromosome-wide association analysis identifies variants in GPR174 as a risk factor for Graves' disease.

Chu X, Shen M, Xie F, Miao XJ, Shou WH, Liu L, Yang PP, Bai YN, Zhang KY, Yang L, Hua Q, Liu WD, Dong Y, Wang HF, Shi JX, Wang Y, Song HD, Chen SJ, Chen Z, Huang W.

J Med Genet. 2013 Jul;50(7):479-85. doi: 10.1136/jmedgenet-2013-101595. Epub 2013 May 10.

3.

The replication of the association of the rs6832151 within chromosomal band 4p14 with Graves' disease in a Polish Caucasian population.

Szymański K, Bednarczuk T, Krajewski P, Płoski R.

Tissue Antigens. 2012 May;79(5):380-3. doi: 10.1111/j.1399-0039.2012.01854.x.

PMID:
22489947
4.

Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.

Yin X, Latif R, Bahn R, Tomer Y, Davies TF.

Thyroid. 2008 Nov;18(11):1201-6. doi: 10.1089/thy.2008.0098.

5.

Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.

Skórka A, Bednarczuk T, Bar-Andziak E, Nauman J, Ploski R.

Clin Endocrinol (Oxf). 2005 Jun;62(6):679-82.

PMID:
15943829
6.

Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.

Yin X, Latif R, Bahn R, Davies TF.

Thyroid. 2012 Jul;22(7):730-6. doi: 10.1089/thy.2012.0007. Epub 2012 Jun 4.

7.

Association of TLR7 and TSHR copy number variation with Graves' disease and Graves' ophthalmopathy in Chinese population in Taiwan.

Liao WL, Wan L, Wang TY, Chen CC, Tse SS, Lu CH, Tsai FJ.

BMC Ophthalmol. 2014 Feb 11;14:15. doi: 10.1186/1471-2415-14-15.

8.

Association between age at diagnosis of Graves' disease and variants in genes involved in immune response.

Jurecka-Lubieniecka B, Ploski R, Kula D, Krol A, Bednarczuk T, Kolosza Z, Tukiendorf A, Szpak-Ulczok S, Stanjek-Cichoracka A, Polanska J, Jarzab B.

PLoS One. 2013;8(3):e59349. doi: 10.1371/journal.pone.0059349. Epub 2013 Mar 27.

9.
10.

Association of HLA-DR, -DQ genotype and CTLA-4 gene polymorphism with Graves' disease in Japanese children.

Iwama S, Ikezaki A, Kikuoka N, Kim HS, Matsuoka H, Yanagawa T, Sato H, Hoshi M, Sakamaki T, Sugihara S.

Horm Res. 2005;63(2):55-60. Epub 2005 Jan 3.

PMID:
15640608
11.

CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population.

Petrone A, Giorgi G, Galgani A, Alemanno I, Corsello SM, Signore A, Di Mario U, Nisticò L, Cascino I, Buzzetti R.

Thyroid. 2005 Mar;15(3):232-8.

PMID:
15785242
12.

The replication of the association of the rs9355610 within 6p27 with Graves' disease.

Ban Y, Tozaki T, Taniyama M.

Autoimmunity. 2013 Sep;46(6):395-8. doi: 10.3109/08916934.2013.780600.

PMID:
24001206
13.

RNASET2, GPR174, and PTPN22 gene polymorphisms are related to the risk of liver damage associated with the hyperthyroidism in patients with Graves' disease.

Zhang Q, Liu S, Guan Y, Chen Q, Zhang Q, Min X.

J Clin Lab Anal. 2018 Feb;32(2). doi: 10.1002/jcla.22258. Epub 2017 May 31.

PMID:
28568286
14.

Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.

Kurylowicz A, Hiromatsu Y, Jurecka-Lubieniecka B, Kula D, Kowalska M, Ichimura M, Koga H, Kaku H, Bar-Andziak E, Nauman J, Jarzab B, Ploski R, Bednarczuk T.

Genes Immun. 2007 Oct;8(7):532-8. Epub 2007 Aug 9.

PMID:
17690684
15.

Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves' disease in three European Caucasian cohorts.

Płoski R, Brand OJ, Jurecka-Lubieniecka B, Franaszczyk M, Kula D, Krajewski P, Karamat MA, Simmonds MJ, Franklyn JA, Gough SC, Jarząb B, Bednarczuk T.

PLoS One. 2010 Nov 25;5(11):e15512. doi: 10.1371/journal.pone.0015512.

16.

Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations.

Bednarczuk T, Hiromatsu Y, Fukutani T, Jazdzewski K, Miskiewicz P, Osikowska M, Nauman J.

Eur J Endocrinol. 2003 Jan;148(1):13-8.

PMID:
12534352
17.

The clinical value of human leukocyte antigen HLA-DRB1 subtypes associated to Graves' disease in Romanian population.

Martin S, Dutescu MI, Sirbu A, Barbu C, Albu A, Florea S, Fica S.

Immunol Invest. 2014;43(5):479-90. doi: 10.3109/08820139.2014.886261. Epub 2014 Mar 24.

PMID:
24661105
18.

Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children.

Chong KK, Chiang SW, Wong GW, Tam PO, Ng TK, Hu YJ, Yam GH, Lam DS, Pang CP.

Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2409-15. doi: 10.1167/iovs.07-1433. Epub 2008 Feb 22.

PMID:
18296657
19.

Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.

Aydın AF, Develi-İş S, Doğru-Abbasoğlu S, Vural P, Ozderya A, Karadağ B, Uysal M.

Int Immunopharmacol. 2014 Jan;18(1):198-202. doi: 10.1016/j.intimp.2013.11.017. Epub 2013 Dec 2.

PMID:
24291390
20.

Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.

Gu LQ, Zhu W, Zhao SX, Zhao L, Zhang MJ, Cui B, Song HD, Ning G, Zhao YJ.

Clin Endocrinol (Oxf). 2010 Feb;72(2):248-55. doi: 10.1111/j.1365-2265.2009.03617.x. Epub 2009 Apr 27.

PMID:
19438904

Supplemental Content

Support Center